[ad_1] Massachusetts General Hospital (MGH) physicians report an unexpected side effect of treatment with dupilumab, approved by the FDA for the treatment of moderate-to-severe eczema, also known as atopic dermatitis. In their …
Read More »
[ad_1] En plus de traiter efficacement un cas résistant de dermatite atopique, le dupilumab, un médicament contre l’eczéma (Dupixent, Regeneron Pharmaceutics) ont déclenché la croissance des cheveux chez un jeune patient présentant …
Read More »
[ad_1] An FDA-approved drug, used to treat eczema, has resulted in hair regrowth in a teenager with alopecia. This unexpected side effect is thought to be the first of its kind – …
Read More »